Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-2018
Corpus(Cr.) 5728.0 Latest NAV 41.47 As on 30-07-2025
Equity(%) 96.46 52 Week High 41.47
Debt(%) 3.54 52 Week Low 33.8
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.89
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 43.91%
Top 10 Holdings 64.50%
Top 25 Holdings 90.39%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 83.67
Healthcare 6.09
Cash 3.54
Miscellaneous 2.49
Retail 1.48
Software & Services 1.44
Chemicals 1.29
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.05
PE Ratio 32.45
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 12.23
DIVI LABORATORIES LTD. 8.95
Dr Reddys Laboratories Limited 8.92
Cipla Limited 7.75
Aurobindo Pharma Limited 6.06
Biocon Limited 5.02
Mankind Pharma Limited 4.20
Alkem Laboratories Limited 4.01
Lupin Limited 3.79
Gland Pharma Limited 3.57
Zydus Lifesciences Limited 3.31
TREPS 2.56
Syngene International Limited 2.39
ALEMBIC PHARMACEUTICALS 1.95
Pfizer Limited 1.94
Shilpa Medicare Limited 1.50
MedPlus Health Services Limited 1.48
Sagility India Limited 1.44
Medi Assist Healthcare Services Limited 1.41
ADVANCED ENZYME TECHNOLOGIE LT 1.41
WINDLAS BIOTEC LTD 1.33
METROPOLIS HEALTHCARE LIMITED 1.32
Thyrocare Technologies Limited 1.29
EQ -FINE ORGANIC IND LTD 1.29
Aarti Drugs Limited 1.27

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
5.28% 11.09% 12.20% 17.05%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-2.43% 2.80% 7.76% 1.27%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
33.00% 29.50% 23.89% 0.00%
 
 
13.82% 14.44% 18.90% 12.79%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection